Studies have shown that a significant proportion (40%) of CHB patients have normal or minimally increased levels of alanine aminotransferase (ALT), while they may still be at the risk of HCC, cirrhotic events, and mortality in patients with CHB-related cirrhosis [4–7]. This evidence concerns the gene GPT and hepatocellular carcinoma.